Scribe Therapeutics Inc. and Sanofi have entered into a strategic collaboration to develop novel Natural Killer (NK) cell therapies for...
Cancer
In February 2022, the Food and Drug Administration (FDA) approved nivolumab with platinum-doublet chemotherapy for adult patients with resectable non-small...
Emirates Oncology Society (EOS) and Ipsen joined forces to raise awareness of Neuroendocrine Tumors (NET), a rare type of cancer....
The FDA approved several medications in May including the following: Infigratinib, a kinase inhibitor for adults with previously treated, unresectable...
Several molecules and indications were approved in April 2021 by FDA. Among the key approvals are the following: Accelerated approval...
The answers to the above question are not, but there is a condition called Barrett’s esophagus where cells that make...
Lung cancer is a malignant lung tumor. It is considered the most common type of cancer in men and the third...
Acute lymphoblastic leukemia (ALL) is a rare type of cancer that affects the lymphoid line of blood cells and characterized...
We are witnessing a new hope for patients with triple-negative breast cancer. The FDA recently approved a new antibody-drug conjugated...
In August 2020, the FDA approved the following (3) products Liquid biopsy next-generation sequencing-based FoundationOne Liquid CDx test for Foundation...
